Moderna Stock Edges Higher Tuesday: What's Happening?
Shares of Moderna are trading higher Tuesday morning, as Wall Street analysts upgrade their ratings following landmark Phase 3 oncology data.
Moderna's stock price went up because experts think the company's cancer medicine test results look really good. When smart people believe a company's new medicine works well, that usually means the company might do better in the future.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.